President Trump's latest executive order modifies the Medicare Drug Price Negotiation Program, aligning the treatment of small molecule drugs with biologics and aiming to reduce drug prices.

Explore the influence of the Inflation Reduction Act on Medicare's prescription cost caps, reducing financial toxicity for patients.

AARP's new report reveals that the prices of top Medicare prescription drugs have nearly doubled over the past decade, raising concerns about affordability for seniors. Discover the implications and legislative efforts to address this crisis.